Protecting Shareholder Value Today
Poison Pills and Takeover Defense Considerations During Pandemic Times
Jul
8
2020
Date: July 8, 2020
Time: 1:00PM - 2:00PM (EST)
Location: View the Webinar Recording
History has shown that extreme stock market volatility often triggers a wave of unsolicited or hostile M&A activity and stockholder activism. Since March of this year, there has been a surge of companies adopting and publicly announcing shareholder rights plans (“poison pills”) to protect stockholders from such predatory activities. Should you be considering the same strategy?
Mintz and Stifel discuss a number of strategic and tactical business, legal, and investment-related considerations, including:
- Lessons learned from the 2020 proxy season and recent wave of poison pill adoptions — mistakes made and winning decisions
- Understanding the modern, evolving role of the poison pill within a broader activism and takeover defense strategy
- Managing internal discussions to drive smart decisions and mechanics for implementing rights plans
Speakers
Matthew J. Gardella
Speaker
Matthew J. Gardella is a Member at Mintz who advises companies, boards of directors, special committees, investment banks, and investors in both buy- and sell-side mergers and acquisitions and other strategic transactions. He counsels public companies on a broad range of corporate, securities, and business-related matters.
Juan I. Bonifacino
Speaker
Managing Director, Activism & Contested Situations, Stifel